The organization and financing of end-stage renal disease treatment in Japan

Shunichi Fukuhara1,2, Chikao Yamazaki3, Yasuaki Hayashino1, Takahiro Higashi1, Margaret A. Eichleay4, Takashi Akiba5, Tadao Akizawa6, Akira Saito7, Friedrich K. Port4, Kiyoshi Kurokawa8
1Department of Epidemiology and Healthcare Research, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan
2Institute for Health Outcomes and Process Evaluation Research, Tokyo, Japan
3Masuko Memorial Hospital, Nagoya, Japan
4Arbor Research Collaborative for Health, Ann Arbor, USA
5Tokyo Women's Medical College, Tokyo, Japan
6Showa University School of Medicine, Tokyo, Japan
7Tokai University School of Medicine, Isehara, Japan
8National Graduate Institute of Policy Study and Health Policy Institute, Tokyo, Japan

Tóm tắt

End-stage renal disease (ESRD) affects 230,000 Japanese, with about 36,000 cases diagnosed each year. Recent increases in ESRD incidence are attributed mainly to increases in diabetes and a rapidly aging population. Renal transplantation is rare in Japan. In private dialysis clinics, the majority of treatment costs are paid as fixed fees per session and the rest are fee for service. Payments for hospital-based dialysis are either fee-for-service or diagnosis-related. Dialysis is widely available, but reimbursement rates have recently been reduced. Clinical outcomes of dialysis are better in Japan than in other countries, but this may change given recent ESRD cost containment policies.

Tài liệu tham khảo

Asai A., Fukuhara S., Lo B. (1995). Attitude of Japanese and Japanese American physicians toward life sustaining treatment. Lancet 346:356–359 Dor, A., Pauly, M. V., Eichleay, M. A., & Held, P. J. (2007). End stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Financing and Economics, DOI: 10.1007/s10754-007-9024-9 Fukuhara S., Lopes A.A., Bragg-Gresham J.L., Kurokawa K., Mapes D.L., Akizawa T., Bommer J., Canaud B.J., Port F.K., Held P.J. (2003). Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney International 64:1903–1910 Hidai H. (2000). Need for an incentive-based reimbursement policy toward quality of care for dialysis care for dialysis patient management. Kidney International 58:363–373 Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9019-6. Iglehart J.K. (1988). Japan’s medical care system—part two. New England Journal of Medicine 319:1166–1172 Ikegami N. (1991). Japanese health care: low cost through regulated fees. Health Affairs 10(3):87–109 Ikegami N., Campbell J.C. (1995). Medical care in Japan. New England Journal of Medicine 333:1295–1299 Japanese Diet (1997). Organ Transplantation Act [in Japanese]. July 16, 1997. Japan Renal Transplantation Society (2003). Renal transplantation: A clinical registration count report 2003 (a follow-up survey) [in Japanese]. Transplant, 4(4), 362–368. Japanese Society for Dialysis Therapy (JSDT) (1999). An overview of regular dialysis treatment in Japan (as of December 31, 1997) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy. Japanese Society for Dialysis Therapy (JSDT) (2002). An overview of regular dialysis treatment in Japan (as of December 31, 2000) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy. Japanese Society for Dialysis Therapy (JSDT) (2005). An overview of regular dialysis treatment in Japan (as of December 31, 2003) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy. Japanese Society for Dialysis Therapy (JSDT) (2006). An overview of regular dialysis treatment in Japan (as of December 31, 2004)[in Japanese]. Tokyo: Japanese Society for Dialysis Therapy [CD Rom]. Japanese Society for Dialysis Therapy (JSDT) (2007). An overview of regular dialysis treatment in Japan (as of December 31, 2005) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy. Retrieved March 9, 2007, at http://www.jsdt.or.jp/overview/index.html Japanese Society for Transplantation (2006). Factbook of organ transplantation in Japan, 2006 [in Japanese]. Retrieved May 22, 2007, at http://www.asas.or.jp/jst/factbook/2006/fact06_03.html Lee H., Manns B.J., Taub K., Ghali W., Dean S., Johnson D., Donaldson C. (2002). Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 40: 611–622 Ministry of Health, Labour and Welfare (MHLW) (2000). National medical care expenditure 1998 [in Japanese]. Tokyo: Welfare Statistics Association. MHLW (1993, 1996, 1999, 2002a). Patient Survey [in Japanese]. Tokyo: Welfare Statistics Association. MHLW (2002b). National Diabetes Survey [in Japanese]. Retrieved May 22, 2007, at http://www.mhlw.go.jp. MHLW (2004). National medical care expenditure 2002 [in Japanese]. Tokyo: Welfare Statistics Association. National Institute of Population and Social Security Research (NIPSSR). (2002). Population projections for Japan: 2001–2050. Tokyo: National Institute of Population and Social Security Research. Oliver A.J., Ikegami N., Ikeda S. (1997). Japan’s aging population; implication for health care. Pharmacoeconomics 11:306–318 OECD (2005). OECD health data 2005. Paris: Organization for Economic Co-operation and Development. OECD (2006). Purchasing power parities (PPPs) for OECD Countries 1980–2005. Paris: Organization for Economic Cooperation and Development. Retrieved April 28, 2006, at http://www.oecd.org/dataoecd/61/56/1876133.xls OECD (2007). OECD statistical profile for Japan – 2006. OECD Statistics v.4.3. Retrieved May 21, 2007, at, http://stats.oecd.org/wbos/viewhtml.aspx?query name=321&querytype=view&lang=en Pisoni R.L., Bragg-Gresham J., Young E.W., Akizawa T., Asano Y., Locatelli F., Bommer J., Cruz J.M., Kerr P.G., Mendelssohn D.C., Held P.J., Port F.K. (2004). Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 44:94–111 Saran R., Bragg-Gresham J.L., Wizemann V., Twardowski Z., Saito A., Levi N.W., Kimata N., Gillespie B.W., Combe C., Bommer J., Akiba T., Young E.W., Port F.K. (2006). Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney International 69:1222–1228 Sugisaki H., Suzuki M., Yoshida T., Yamazaki C. (2004). Ground-design in hemodialysis therapy [in Japanese]. Journal Japanese Association Dialysis Physicians 19(3):468–479 Sugisaki, H., Ohta, Y., Ohira, S., Onoyama, T., Kuma, H., Suzuku, M., Yamakawa, T., Yoshida, T., Ono, T., Tozawa, S., Miyamoto, T., & Yamazaki, C. (2007). The 10t dialysis practice survey [in Japanese]. Journal of the Japanese Association of Dialysis Physicians, 21(2) (in press). Suzuki M., Sugisaki H., Yoshida T., Yamazaki C. (2002). The 5t dialysis practice survey [in Japanese]. Journal of the Japanese Association of Dialysis Physicians 17(2):183–226 Tsuji-Hayashi Y. Fukuhara S., Oshima S., Uchida K., Green J., Takai I., Maeda K. (1999). Health-related quality of life among renal transplant patients in Japan. Transplantation 68:1331–1335 World Bank (2005). 2005 World development indicators. Washington, D.C.: The World Bank Group. World Health Organization (WHO) (2006). Annex table 1: basic indicators for all member states. In The World Health Report 2006: Working Together for Health. Geneva, Switzerland: World Health Organization. Retrieved September 18, 2006 at http://www.who.int/whr/2006/annex/en.